Testing effectiveness (Phase 2)Not Yet RecruitingNCT07297550
What this trial is testing
Safety and Efficacy of the JAK1 Inhibitor Combined With Intensive Immunosuppressive Therapy in Severe Aplastic Anemia
Who this might be right for
Severe Aplastic AnemiaRefractory Aplastic AnemiaNewly Diagnosed Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China 42